Targeted therapy
A modern approach that targets the tumour’s molecular drivers — mutations, receptors, signalling pathways. Includes tyrosine kinase, angiogenesis, PARP and mTOR inhibitors, plus ADCs.
What this method includes
- Tyrosine kinase inhibitors (TKIs)
- Angiogenesis inhibitors
- PARP inhibitors — especially in BRCA-mutated tumours
- mTOR inhibitors
- HER2-targeted agents
- CDK4/6 inhibitors
Important
The method and protocol are chosen individually after an in-person specialist consultation and review of the medical record.
World-class clinics across China
Lu Daopei Hospital
A network of haematology and oncology clinics with one of the largest CAR-T programmes worldwide.
Beijing Lu Daopei Hospital
The Beijing branch — international patient intake and outpatient programmes.
Hebei Yanda Lu Daopei Hospital
The network’s large inpatient facility for extended programmes and transplants.
Clifford Hospital
A JCI-class multidisciplinary hospital with oncology, integrative and rehabilitation programmes.
Beijing Jingdu Children’s Hospital
A specialised children’s hospital with paediatric oncology and haematology.
Tell us about your case — we will call you back.
A free consultation. Reply within one business day. No commitment.